Drug Shortage Report for AIROMIR

Last updated on 2018-06-12 History
Report ID 43777
Drug Identification Number 02232570
Brand name AIROMIR
Common or Proper name AIROMIR
Company Name BAUSCH HEALTH, CANADA INC.
Market Status MARKETED
Active Ingredient(s) SALBUTAMOL
Strength(s) 100MCG
Dosage form(s) METERED-DOSE AEROSOL
Route of administration INHALATION
Packaging size n/a
ATC code R03AC
ATC description ADRENERGICS, INHALANTS
Reason for shortage Other (Please describe in comments)
Anticipated start date
Actual start date 2018-03-21
Estimated end date
Actual end date 2018-06-11
Shortage status Resolved
Updated date 2018-06-12
Company comments
Health Canada comments
Tier 3 Status No
Contact Address 2150 BOUL. ST-ELZEAR OUEST
LAVAL, QUEBEC
CANADA H7L 4A8
Company contact information

Version History

Click on "Compare" below to view the full report history and compare to other versions.

Version Number Date Updated Language
v19 2018-06-12 English Compare
v18 2018-06-11 French Compare
v17 2018-06-11 English Compare
v16 2018-06-08 French Compare
v15 2018-06-08 English Compare
v14 2018-06-01 French Compare
v13 2018-06-01 English Compare
v12 2018-05-30 French Compare
v11 2018-05-30 English Compare
v10 2018-05-17 French Compare
v9 2018-05-17 English Compare
v8 2018-05-11 French Compare
v7 2018-05-11 English Compare
v6 2018-05-04 French Compare
v5 2018-05-04 English Compare
v4 2018-04-18 French Compare
v3 2018-04-18 English Compare
v2 2018-03-23 French Compare
v1 2018-03-23 English Compare

Showing 1 to 19 of 19